期刊文献+

穿心莲内酯NO供体衍生物的合成 被引量:3

Synthesis of the Derivatives of Andrographolide for NO Donor
下载PDF
导出
摘要 利用协同前药原理,在穿心莲内酯衍生物的结构上引入硝酸酯,合成了硝酸酯NO供体新化合物9个,以期找到生物利用度更高、抗癌作用更好的新药;目标化合物结构经1HNMR,13CNMR和MS确证. The mutual prodmg principle was applied to andrographolide derivatives. Nine compounds of NO donors were synthesized in order to find out new medicines of high bioavailability and good anticancer effect. All the target compounds have been identified by ^1H NMR, ^13c NMR and MS spectra.
出处 《有机化学》 SCIE CAS CSCD 北大核心 2005年第11期1386-1391,共6页 Chinese Journal of Organic Chemistry
基金 国家教育部科技司基金(No.[2003]64号-12)资助项目.
关键词 协同前药 穿心莲内酯 NO供体 生物利用度 衍生物 合成 供体 化合物结构 新化合物 抗癌作用 mutual prodmg principle andrographolide NO donor bioavailability
  • 相关文献

参考文献7

  • 1林启寿.中草药有效成分[M].北京:化学工业出版社,1965年.624-626.
  • 2赵守训.中药大词典 下册[M].南京:江苏出版社,1992.1580-1584.
  • 3Srinivas, N.; Vijay, K.; Siva, S.; Rao, T. Bioorg. Med. Chem.Lett. 2004, 14(18), 4711.
  • 4Tsumori, M.; Tanaka, J.; Koshimura, K. Acta Biochim. Pol.2002, 49(1), 139.
  • 5王艳,丁虹,肖庚富.一氧化氮介导的肿瘤治疗研究进展[J].癌症,2004,23(4):476-479. 被引量:13
  • 6Nanduri, S.; Rajagopal, S.; Akella, V. WO 2001085709,2001 [Chem. Abstr. 2001, 135, 358071].
  • 7Satoh, T.; Nanba, K.; Suzuki, S. Chem. Pharm. Bull. 1971,19(4), 817.

二级参考文献25

  • 1Jenkins DC,Charles IG,Thomsen LL,et al. Roles of nitric oxide in tumor growth [J]. Proc Natl Acad Sci U S A,1995,92(10):4392- 4396.
  • 2Kiechle FL,Zhang X. Apoptosis:biochemical aspects and clinical implications [J]. Clin Chim Acta,2002,326(1- 2):27- 45.
  • 3Moncada S,Palmer RM,Higgs EA. Nitric oxide:physiology, pathophysiology, and pharmacology [J].Pharmacol Rev,1991,43(2):109- 142.
  • 4Soliman MK,Mazzio E,Soliman KF. Levodopa modulating effects of inducible nitric oxide synthase and reactive oxygen species in glioma cells [J]. Life Sci,2002,72(2):185- 198.
  • 5Jurasz P,Sawicki G,Duszyk M,et al. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation:regulation by nitric oxide [J]. Cancer Res,2001,61(1):376- 382.
  • 6Lala PK,Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression [J]. Lancet Oncol,2001,2(3):149- 156.
  • 7Maurer TS,Fung HL. Evaluation of nitric oxide synthase activity and inhibition kinetics by chemiluminescence [J]. Nitric Oxide,2000,4(4):372- 378.
  • 8Zaks-Zilberman M,Zaks TZ,Vogel SN. Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines [J]. Cytokine,2001,15(3):156- 165.
  • 9Loibl S,von Minckwitz G,Weber S, et al. Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy [J]. Cancer,2002,15,95(6):1191- 1198.
  • 10Park CS,Park R,Krishna G. Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues [J]. Life Sci,1996,59(3):219- 225.

共引文献15

同被引文献32

引证文献3

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部